116 related articles for article (PubMed ID: 34752544)
1. Stability and Beyond-Use Date of a Compounded Thioguanine Suspension.
Gilda SS; Kolling WM; Nieto M; McPherson T
J Pharm Technol; 2021 Feb; 37(1):23-29. PubMed ID: 34752544
[No Abstract] [Full Text] [Related]
2. Stability of Olmesartan Medoxomil Extemporaneous Suspensions.
Bhattarai P; McPherson T; Nieto M; Kolling WM
J Pharm Technol; 2022 Feb; 38(1):3-9. PubMed ID: 35141721
[No Abstract] [Full Text] [Related]
3. Stability of compounded thioguanine oral suspensions.
Aliabadi HM; Romanick M; Somayaji V; Mahdipoor P; Lavasanifar A
Am J Health Syst Pharm; 2011 May; 68(10):900-8. PubMed ID: 21546641
[TBL] [Abstract][Full Text] [Related]
4. Stability of a pyrimethamine suspension compounded from bulk powder.
Lewis PO; Cluck DB; Huffman JD; Ogle AP; Brown SD
Am J Health Syst Pharm; 2017 Dec; 74(24):2060-2064. PubMed ID: 29222363
[TBL] [Abstract][Full Text] [Related]
5. Stability of Azathioprine, Clonidine Hydrochloride, Clopidogrel Bisulfate, Ethambutol Hydrochloride, Griseofulvin, Hydralazine Hydrochloride, Nitrofurantoin, and Thioguanine Oral Suspensions Compounded with SyrSpend SF pH4.
Polonini H; da Silva SL; Cunha CN; Ferreira AO; Anagnostou K; Dijkers E
Int J Pharm Compd; 2020; 24(3):252-262. PubMed ID: 32401746
[TBL] [Abstract][Full Text] [Related]
6. The stability of quetiapine oral suspension compounded from commercially available tablets.
Tran J; Gervase MA; Evans J; Deville R; Dong X
PLoS One; 2021; 16(8):e0255963. PubMed ID: 34375349
[TBL] [Abstract][Full Text] [Related]
7. Evaluation of the Stability of Mercaptopurine Suspension Compounded in a Commercial Vehicle and the Determination of an Appropriate Beyond-use Date.
Peacock GF; Sauvageot J; Hill A; Killian A
Int J Pharm Compd; 2016; 20(1):81-5. PubMed ID: 27125058
[TBL] [Abstract][Full Text] [Related]
8. Stability of extemporaneously prepared cinacalcet oral suspensions.
Thomson K; Hutchinson DJ; Chablani L
Am J Health Syst Pharm; 2018 May; 75(9):e236-e240. PubMed ID: 29691267
[TBL] [Abstract][Full Text] [Related]
9. Stability and uniformity of extemporaneous preparations of voriconazole in two liquid suspension vehicles at two storage temperatures.
Nguyen KQ; Hawkins MG; Taylor IT; Wiebe VJ; Tell LA
Am J Vet Res; 2009 Jul; 70(7):908-14. PubMed ID: 19566477
[TBL] [Abstract][Full Text] [Related]
10. Stability of extemporaneously prepared rufinamide oral suspensions.
Hutchinson DJ; Liou Y; Best R; Zhao F
Ann Pharmacother; 2010 Mar; 44(3):462-5. PubMed ID: 20150505
[TBL] [Abstract][Full Text] [Related]
11. Formulation and stability of an extemporaneously compounded propafenone hydrochloride oral suspension for children with arrhythmia.
Lin YS; Lin SC; Hsieh YT; Liu LY; Lin CH; Shen LJ; Huang CF
Eur J Hosp Pharm; 2022 Nov; 29(6):324-328. PubMed ID: 33608396
[TBL] [Abstract][Full Text] [Related]
12. Temozolomide stability in extemporaneously compounded oral suspensions.
Trissel LA; Zhang Y; Koontz SE
Int J Pharm Compd; 2006; 10(5):396-9. PubMed ID: 23974320
[TBL] [Abstract][Full Text] [Related]
13. Stability of two concentrations of tiagabine in an extemporaneously compounded suspension.
Haase MR; Khan MA; Bonilla J
Int J Pharm Compd; 2003; 7(6):485-9. PubMed ID: 23979810
[TBL] [Abstract][Full Text] [Related]
14. Naratriptan hydrochloride in extemporaneosly compounded oral suspensions.
Zhang YP; Trissel LA; Fox JL
Int J Pharm Compd; 2000; 4(1):69-71. PubMed ID: 23985892
[TBL] [Abstract][Full Text] [Related]
15. Stability of extemporaneously prepared moxifloxacin oral suspensions.
Hutchinson DJ; Johnson CE; Klein KC
Am J Health Syst Pharm; 2009 Apr; 66(7):665-7. PubMed ID: 19299374
[TBL] [Abstract][Full Text] [Related]
16. Stability of Extemporaneously Prepared Acetazolamide Oral Suspensions at Two Temperatures.
Gillium C; Friciu M; Abatzoglou N; Leclair G
J Pediatr Pharmacol Ther; 2020; 25(8):723-729. PubMed ID: 33214784
[TBL] [Abstract][Full Text] [Related]
17. Stability of extemporaneously prepared glycopyrrolate oral suspensions.
Cober MP; Johnson CE; Sudekum D; Penprase K
Am J Health Syst Pharm; 2011 May; 68(9):843-5. PubMed ID: 21515869
[TBL] [Abstract][Full Text] [Related]
18. Stability of Extemporaneously Prepared Hydroxycarbamide Oral Suspensions.
Kabiche D; Balde IB; Majoul E; Kabiche S; Bourguignon E; Fontan JE; Cisternino S; Schlatter J
Int J Pharm Compd; 2017; 21(2):160-163. PubMed ID: 28346212
[TBL] [Abstract][Full Text] [Related]
19. Formulation and Stability Study of Eslicarbazepine Acetate Oral Suspensions for Extemporaneous Compounding.
Zhao F; Dave VS; Mar MZ; Perri JR
Int J Pharm Compd; 2018; 22(5):433-439. PubMed ID: 30384342
[TBL] [Abstract][Full Text] [Related]
20. Stability of an extemporaneously prepared alcohol-free phenobarbital suspension.
Cober MP; Johnson CE
Am J Health Syst Pharm; 2007 Mar; 64(6):644-6. PubMed ID: 17353574
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
